On this page
-
…
About the minimum quality standard
The minimum quality standard is used to verify medicinal cannabis products which have been derived from the Cannabis plant. Medicinal cannabis products that meet the minimum quality standard and can be prescribed in New Zealand are listed on this page.
The minimum quality standard for medicinal cannabis products is set out in the Misuse of Drugs (Medicinal Cannabis) Regulations 2019. The standard ensures the quality and consistency of medicinal cannabis products doctors prescribe to patients.
The standard applies to products derived from the cannabis plant. It does not apply to synthetic CBD and THC products.
Products that meet the minimum quality standard are not approved medicines. That means their safety and efficacy has not been assessed.
Who can prescribe medicinal cannabis products
Any doctor can prescribe the medicinal cannabis products on this page. You do not need a specialist recommendation or Ministerial approval. For more information on a particular product, please contact the listed product supplier or manufacturer.
About medicinal cannabis products that meet the minimum quality standard
Medicinal cannabis products that meet the minimum quality standard and can be prescribed in New Zealand, are listed on this page. Some verified products may not be listed here at the request of the licence holder. Being listed here does not guarantee that these products are currently available in New Zealand. For the most up-to-date information on product availability, contact the licence holder.
Generally, medicinal cannabis products are only available on prescription if they have:
- been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
- obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines).
Dosage products classified as prescription medicine
The products listed in the tables are categorised by their verified dosage form. The products meet the testing requirements and microbiological contamination limits applicable to the dosage form as listed.
Oral Liquids
| Product Name | Active Ingredients | Pack Sizes (mL) | Administration notes | Licence holder |
|---|---|---|---|---|
| Helius CBD25 Full Spectrum | Total CBD (CBD+CBDA) 25 mg/mL | 30 | Oral, withdraw prescribed dose using provided dropper and dispense into mouth | Helius Therapeutics Limited |
| Helius CBD100 Full Spectrum | Total CBD (CBD+CBDA) 100 mg/mL | 30 | Oral, withdraw prescribed dose using provided dropper and dispense into mouth | Helius Therapeutics Limited |
| Tilray P Oral Solution CBD 100 | Total CBD (CBD+CBDA) 106.4 mg/g (100 mg/mL) | 25, 40 | Oral, 1 mL oral syringe with 0.1 mL volume markings | CDC Pharmaceuticals Ltd |
| Tilray P Oral Solution CBD 25 | Total CBD (CBD+CBDA) 26.6 mg/g (25 mg/mL) | 40 | Oral, 1 mL oral syringe with 0.1mL volume markings | CDC Pharmaceuticals Ltd |
| ANTG Elan Oil [CBD100] | Total CBD (CBD+CBDA) 100 mg/mL | 30, 100 | Oral via 1.5 mL LDPE standard syringe | MW Pharma Limited t/a NUBU Pharmaceuticals |
Sublingual Solutions
| Product Name | Active Ingredients | Pack Sizes (mL) | Administration notes | Licence holder |
|---|---|---|---|---|
| Helius SubDrops® CBD100 | Total CBD (CBD+CBDA) 100 mg/mL | 30 | Sublingual, 1 mL dropper with 0.25 mL volume markings | Helius Therapeutics Limited |
| Helius SubDrops® CBD25 | Total CBD (CBD+CBDA) 25 mg/mL | 30 | Sublingual, 1 mL dropper with 0.25 mL volume markings | Helius Therapeutics Limited |
| Eqalis CBD120 | Total CBD (CBD+CBDA) = 120 mg/mL Total THC (Δ9-THC+THCA) < 0.5 mg/mL | 30 | Sublingual, 1 mL dropper with 0.25 mL volume markings | Eqalis Pharmaceuticals Limited |
| Eqalis CBD30 | Total CBD (CBD+CBDA) = 30 mg/mL Total THC (Δ9-THC+THCA) < 0.6 mg/mL | 30 | Sublingual, 1 mL dropper with 0.25 mL volume markings | Eqalis Pharmaceuticals Limited |
Dosage Products - Controlled Drug B1
Oral Liquids
| Product Name | Active Ingredients | Pack Sizes (mL) | Administration notes | Licence holder |
|---|---|---|---|---|
| evalaCann THC ≤1 mg: CBD 20 mg | Total THC (THC+THCA) ≤1 mg Total CBD (CBD+CBDA) 20 mg | 30 | Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings | Cannasouth Bioscience Ltd |
| evalaCann THC 10 mg: CBD 15 mg | Total THC (THC+THCA) 10 mg Total CBD (CBD+CBDA) 15 mg | 30 | Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings | Cannasouth Bioscience Ltd |
| evalaCann THC 10 mg: CBD ≤1 mg | Total THC (THC+THCA) 10 mg Total CBD (CBD+CBDA) ≤1 mg | 30 | Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings | Cannasouth Bioscience Ltd |
| Helius THC25 Full Spectrum | Total THC (THC+THCA) 25 mg/mL Total CBD (CBD+CBDA) ≤2 mg/mL | 30 | Oral, withdraw prescribed dose with provided oral syringe and dispense into mouth. Provided with 1 mL oral syringe with 0.1mL markings | Helius Therapeutics Limited |
| Helius THC10:CBD10 Full Spectrum | Total THC (THC+THCA) 10 mg/mL Total CBD (CBD+CBDA) 10 mg/mL | 30 | Oral, withdraw prescribed dose with provided oral syringe and dispense into mouth. Provided with 1 mL oral syringe with 0.1mL markings | Helius Therapeutics Limited |
| Tilray FS oral Solution THC 25 | Total THC (THC+THCA) 26.44 mg / g (25 mg/ mL) | 40 | Oral, 1 mL oral syringe with 0.1 mL volume markings | CDC Pharmaceuticals Ltd |
| Tilray FS Oral Solution THC 10 CBD 10 | Total THC (THC+THCA) 10.5 mg/g (10 mg/mL) Total CBD (CBD+CBDA) 10.5 mg/g (10 mg/mL) | 40 | Oral, 1 mL oral syringe with 0.1 mL volume markings | CDC Pharmaceuticals Ltd |
| Tilray FS Oral Solution THC 5: CBD 20 | Total THC (THC+THCA) 5.3 mg/g (5 mg/mL) Total CBD (CBD+CBDA) 21.3 mg/g (20 mg/mL) | 40 | Oral, 1 mL oral syringe with 0.1 mL volume markings | CDC Pharmaceuticals Ltd |
| ANTG Rocky Oil [FS THC30 CBD<1] | Total THC (THC+THCA) 30 mg/mL Total CBD (CBD+CBDA) < 1 mg/mL | 50 | Oral via 1.5 mL LDPE standard syringe | MW Pharma Limited t/a NUBU Pharmaceuticals |
| ANTG Luna Oil [FS THC10 CBD10] | Total THC (THC+THCA) 10 mg/mL Total CBD (CBD+CBDA) 10 mg/mL | 50 | Oral via 1.5 mL LDPE standard syringe | MW Pharma Limited t/a NUBU Pharmaceuticals |
| ANTG Eve Oil [FS THC2 CBD50] | Total THC (THC+THCA) ≤ 2 mg/mL Total CBD (CBD+CBDA) 50 mg/mL | 50 | Oral via 1.5 mL LDPE standard syringe | MW Pharma Limited t/a NUBU Pharmaceuticals |
Dried cannabis flower for inhalation via a vaporiser
These medicinal cannabis products are Class C1 controlled drugs. They meet the minimum quality standard for inhalation via a vaporiser.
Product Name | Active Ingredients | Pack Sizes (g) | Administration notes | Licence holder |
|---|---|---|---|---|
| KIKUYA Dune | Total THC (THC+THCA) 190 mg/g (19% w/w) Total CBD (CBD+CBDA) ≤10 mg/g (≤1%w/w) | 10 | Inhalation via vaporiser | MW Pharma Limited t/a NUBU Pharmaceuticals |
| KIKUYA Arroyo | Total THC (THC+THCA) 200 mg/g (20% w/w) Total CBD (CBD+CBDA) ≤10 mg/g (≤1% w/w) | 10 | Inhalation via vaporiser | MW Pharma Limited t/a NUBU Pharmaceuticals |
| Tilray Whole Flower Dried Cannabis THC 22 | Total THC (THC+THCA) 22 % w/w Total CBD (CBD+CBDA) ≤1% w/w | 15 | Inhalation via vaporiser | CDC Pharmaceuticals Ltd |
| Equiposa | Total THC (THC+THCA) 9.0 % w/w Total CBD (CBD+CBDA) 8.3 % w/w | 15 | Inhalation via vaporiser | Indica Industries Ltd |
| Luminarium | Total THC (THC+THCA) 22.5 % w/w Total CBD (CBD+CBDA) ≤1 % w/w | 15 | Inhalation via vaporiser | Indica Industries Ltd |
| Sedaprem | Total THC (THC+THCA) 21.3 % w/w Total CBD (CBD+CBDA) ≤1% w/w | 15 | Inhalation via vaporiser | Indica Industries Ltd |
| KIKUYA Peak | Total THC (THC+THCA) 255 mg/g (25.5 % w/w) Total CBD (CBD+CBDA) ≤10 mg/g (≤1% w/w) | 10 | Inhalation via vaporiser | MW Pharma Limited t/a NUBU Pharmaceuticals |
| Helius DK Dusk THC25 | Total THC (THC+THCA) 25 % w/w Total CBD (CBD+CBDA) ≤ 1 % w/w | 10 | Inhalation via vaporiser | Helius Therapeutics Limited |
| Helius DK Dawn THC22 | Total THC (THC+THCA) 22 % w/w Total CBD (CBD+CBDA) ≤ 1 % w/w | 10 | Inhalation via vaporiser | Helius Therapeutics Limited |
| Tilray Whole Flower Dried Cannabis THC 25 | Total THC (THC+THCA) 25 % w/w Total CBD (CBD+CBDA) ≤1% w/w | 15 | Inhalation via vaporiser | CDC Pharmaceuticals Ltd |
| KIKUYA Cove | Total THC (THC+THCA) 190 mg/g (19.0 % w/w) Total CBD (CBD+CBDA) ≤10 mg/g (≤1% w/w) | 10 | Inhalation via vaporiser | MW Pharma Limited t/a NUBU Pharmaceuticals |
| Rua Puāwai THC26 | Total THC (THC + THCA) 26 % w/w Total CBD (CBD + CBDA) ≤ 1 % w/w | 10 | Inhalation via vaporiser | Rua Bioscience Limited |
| Rua Puāwai THC18 White Widow | Total THC (THC + THCA) 18 % w/w Total CBD (CBD + CBDA) < 1 % w/w | 10 | Inhalation via vaporiser | Rua Bioscience Limited |
Dried cannabis flower for preparing tea for oral consumption
These medicinal cannabis products are Class C1 controlled drugs. They meet the minimum quality standard for the preparation of tea for oral consumption.
These products do not meet the minimum quality standard for inhalation.
Product Name | Active Ingredients | Pack Sizes (g) | Administration notes | Licence holder |
|---|---|---|---|---|
| ANTG Eve | Total THC (THC+THCA) 10 mg/g (˂ 1% w/w) Total CBD (CBD+CBDA) 125 mg/g (12.5% w/w) | 10 | Tea preparation for oral consumption. | MW Pharma Limited t/a NUBU Pharmaceuticals |
| ANTG Mariposa | Total THC (THC+THCA) 135 mg/g (13.5% w/w) Total CBD (CBD+CBDA) <10 mg/g (<1% w/w) | 10 | Tea preparation for oral consumption. | MW Pharma Limited t/a NUBU Pharmaceuticals |
| ANTG Rocky | Total THC (THC+THCA) 250 mg/g (25% w/w) Total CBD (CBD+CBDA) <10 mg/g (<1% w/w) | 10 | Tea preparation for oral consumption. | MW Pharma Limited t/a NUBU Pharmaceuticals |
| ANTG Solace | Total THC (THC+THCA): 200 mg/g (20% w/w) Total CBD (CBD+CBDA): <10 mg/g (<1% w/w) | 10 | Tea preparation for oral consumption. View tea preparation instructions | MW Pharma Limited t/a NUBU Pharmaceuticals |
| Medleaf Shishkaberry | Total THC (THC+THCA): 16% w/w Total CBD (CBD+CBDA): 1% w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf Zour Apple | Total THC (THC+THCA) 23% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf GG#4 | Total THC (THC+THCA) 24% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf LL Kush | Total THC (THC+THCA) 23% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Cumulus T17 | Total THC (THC+THCA) = 17% w/w Total CBD (CBD + CBDA) <2% w/w | 10 | Tea preparation for oral consumption. View tea preparation instructions | Cannasouth Cultivation Limited |
| Symetis T17 B52 | Total THC (THC+THCA) = 17% w/w Total CBD (CBD + CBDA) <2% w/w | 10 | Tea preparation for oral consumption. View tea preparation instructions | Cannasouth Cultivation Limited |
| Medleaf Orange Kush C | Total THC (THC+THCA) 21% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf Tropicana | Total THC (THC+THCA) 16% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf Runtz M | Total THC (THC+THCA) 20% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| Medleaf MAC-1 | Total THC (THC+THCA) 22% w/w Total CBD (CBD+CBDA) <1%w/w | 30 | Tea preparation for oral consumption. View tea preparation instructions | JC logistics t/a Medleaf Therapeutics |
| ANTG Duke | Total THC (THC+THCA) 24.5% w/w Total CBD (CBD+CBDA) <1% w/w | 10 | Tea preparation for oral consumption. View tea preparation instructions | MW Pharma Limited t/a NUBU Pharmaceuticals |
How to prepare dried cannabis flower tea
Steps for tea preparation
- Grind the product in a grinder until fine.
- Bring 500 mL of water to the boil in a covered saucepan.
- Add 0.5 grams of the ground product to the boiling water.
- Turn down the heat and simmer the tea for 15 minutes. Keep the saucepan covered.
- Remove the saucepan from the heat and strain the tea.
- Add a sachet of coffee creamer to the warm tea before drinking. This prevents the active ingredients from sticking to the teapot or mug when the tea cools down.
Leftover tea can be stored in a thermos if you plan to drink it on the same day.
Products with consent for distribution
These medicinal cannabis products have been approved or provisionally approved under the Medicines Act 1981. They have been assessed by Medsafe and meet New Zealand and international standards for quality, safety and efficacy.
| Product Name | Active Ingredients | Dose Form | Prescribing information | Information for consumers | Sponsor |
|---|---|---|---|---|---|
| Sativex oromucosal spray | CBD 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg THC 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg | Oromucosal spray | Sativex data sheet (191 KB) | Sativex consumer medicine information (PDF, 210 KB) | Chiesi New Zealand Limited t/a Emerge Health |
| Epidyolex oral solution | Cannabidiol 100 mg/mL | Oral solution | Epidyolex data sheet (PDF, 424 KB) | Epidyolex consumer medicine information (PDF, 347 KB) | Chiesi New Zealand Limited t/a Emerge Health |
